These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 167665)

  • 1. Psoriatic therapeutics and glucose-6-phosphate dehydrogenase.
    Cotton DW; van Rossum E
    Arch Dermatol Forsch; 1975; 252(2):147-9. PubMed ID: 167665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitory action of glucocorticoids on glucose-6-phosphate dehydrogenase activty. A screening of antipsoriatic effects (author's transl)].
    Raab W; Siber H
    Arch Dermatol Forsch; 1974 Jun; 249(4):357-66. PubMed ID: 4407433
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucose-6-phosphate dehydrogenase in the blood of psoriatics, and the effects of methotrexate.
    Cotton DW; van Rossum E
    Dermatologica; 1973; 147(6):399-405. PubMed ID: 4150922
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro evaluation of methotrexate and azathioprine for antipsoriatic activity.
    Raab W; Gmeiner B
    Arch Dermatol Res (1975); 1975 Aug; 253(1):77-84. PubMed ID: 1190831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibition of glucose-6-phosphate dehydrogenase activity by dithranol (anthralin), zinc ions and/or salicylic acid.
    Raab W; Gmeiner B
    Arch Dermatol Forsch; 1974; 251(2):87-94. PubMed ID: 4447386
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of glucose-6-phosphate dehydrogenase activity by betamethasone and three of its esters with dermatological importance.
    Raab WP; Gmeiner BM
    Arch Dermatol Res (1975); 1975 Sep; 253(2):113-8. PubMed ID: 1103754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme increase by folate and methotrexate in cultured mammalian cells.
    Hillcoat BL; Marshall L
    Can J Biochem; 1974 Dec; 52(12):1132-6. PubMed ID: 4447902
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic changes in the psoriatic lesion during therapy.
    van de Kerkhof PC; Fleuren E; van Rennes H; Mier PD
    Br J Dermatol; 1984 Apr; 110(4):411-5. PubMed ID: 6712885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of some drugs on human erythrocyte glucose 6-phosphate dehydrogenase: an in vitro study.
    Akkemik E; Budak H; Ciftci M
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):871-5. PubMed ID: 21054237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Steroids and skin. V. Plasma dehydroepiandrosterone and erythrocyte glucose-6-phosphate dehydrogenase activity in psoriatic patients before and after the administration of dehydroepiandrosterone sulfate].
    Oertel GW; Menzel P; Hoffmann G; Holzmann H; Morsches B; Gebhardt R
    Z Klin Chem Klin Biochem; 1971 Jan; 9(1):28-30. PubMed ID: 4252824
    [No Abstract]   [Full Text] [Related]  

  • 11. [Senecioyldithranol and beta-carbethoxypropionyldithranol: synthesis and glucose-6-phosphate dehydrogenase inhibition of two new 10-acyl derivatives of the antipsoriatic, dithranol].
    Rychener M; Steiger W; Krebs A
    Pharm Acta Helv; 1988; 63(4-5):111-6. PubMed ID: 3222264
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro effects of rosmarinic acid on glutathione reductase and glucose 6-phosphate dehydrogenase.
    Tandogan B; Kuruüzüm-Uz A; Sengezer C; Güvenalp Z; Demirezer LÖ; Ulusu NN
    Pharm Biol; 2011 Jun; 49(6):587-94. PubMed ID: 21554000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glucose-6-phosphate dehydrogenase and topical antipsoriatics. A comparison of anthralin, anthralin-monoacetate, anthralin-diacetate, anthralin-triacetate and 6-hydroxy-2-oxobenzoxathiole (author's transl)].
    Raab W; Siber H
    Arch Dermatol Forsch; 1974; 249(2):179-89. PubMed ID: 4418435
    [No Abstract]   [Full Text] [Related]  

  • 14. Folates as inhibitors of glutamate dehydrogenase.
    White WE; Yielding LK; Krumdieck CL
    Biochim Biophys Acta; 1976 May; 429(3):689-93. PubMed ID: 178372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of enzymes by an antipsoriatic substance].
    Schaeter H
    Arzneimittelforschung; 1967 Oct; 17(10):1306-10. PubMed ID: 5632884
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucose-6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability.
    Leopold JA; Cap A; Scribner AW; Stanton RC; Loscalzo J
    FASEB J; 2001 Aug; 15(10):1771-3. PubMed ID: 11481225
    [No Abstract]   [Full Text] [Related]  

  • 17. Glyceraldehydephosphate dehydrogenase and glucose-6-phosphate dehydrogenase activities in psoriasis and neurodermatitis and the effect of dithranol.
    Hammar H
    J Invest Dermatol; 1970 Feb; 54(2):121-5. PubMed ID: 5412727
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biochemical studies on the chemotherapy of psoriasis].
    Schaefer H
    Arch Klin Exp Dermatol; 1970; 237(1):240-5. PubMed ID: 4392036
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of psoriasis using dehydroepiandrosterone-enanthate].
    Holzmann H; Morsches B; Krapp R; Hoffmann G; Oertel GW
    Z Haut Geschlechtskr; 1972 Feb; 47(3):99-110. PubMed ID: 4259836
    [No Abstract]   [Full Text] [Related]  

  • 20. Folate supplementation during methotrexate therapy for patients with psoriasis.
    Strober BE; Menon K
    J Am Acad Dermatol; 2005 Oct; 53(4):652-9. PubMed ID: 16198787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.